- Filed
- Apr 27, 2016 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2016 · Apr 22, 2016 | 76.95M sh |
| Shares Diluted | Q1 2016 · Mar 25, 2016 | 79M sh |
| Shares Diluted | Q1 2016 · Mar 27, 2015 | 83.8M sh |
| Stock Repurchased | Q1 2016 · Mar 25, 2016 | $198M |
| Stock Repurchased | Q1 2016 · Mar 27, 2015 | $100M |
| Dividends Paid | Q1 2016 · Mar 25, 2016 | $58M |
| Dividends Paid | Q1 2016 · Mar 27, 2015 | $58M |
| Capex | Q1 2016 · Mar 25, 2016 | $35M |
| Capex restated | Q1 2016 · Mar 27, 2015 | $40M |
| Long Term Debt | Q1 2016 · Mar 25, 2016 | $3.13B |
| Long Term Debt | Q1 2016 · Dec 31, 2015 | $3.13B |
| Cash And Equivalents | Q1 2016 · Mar 25, 2016 | $534M |
| Cash And Equivalents | Q1 2016 · Dec 31, 2015 | $207M |
| Cash And Equivalents | Q1 2016 · Mar 27, 2015 | $317M |
| Cash And Equivalents | Q1 2016 · Dec 31, 2014 | $442M |
| Stockholders Equity | Q1 2016 · Mar 25, 2016 | $4.38B |
| Stockholders Equity | Q1 2016 · Dec 31, 2015 | $4.36B |
| Current Liabilities | Q1 2016 · Mar 25, 2016 | $2.68B |
| Current Liabilities | Q1 2016 · Dec 31, 2015 | $2.88B |
| Total Liabilities | Q1 2016 · Mar 25, 2016 | $7.46B |
| Total Liabilities | Q1 2016 · Dec 31, 2015 | $7.64B |
| Current Assets | Q1 2016 · Mar 25, 2016 | $4.06B |
| Current Assets | Q1 2016 · Dec 31, 2015 | $4.23B |
| Total Assets | Q1 2016 · Mar 25, 2016 | $11.91B |
| Total Assets | Q1 2016 · Dec 31, 2015 | $12.07B |
| Eps Diluted | Q1 2016 · Mar 25, 2016 | $2.87 |
| Eps Diluted | Q1 2016 · Mar 27, 2015 | $1.25 |
| Eps Basic | Q1 2016 · Mar 25, 2016 | $2.92 |
| Eps Basic | Q1 2016 · Mar 27, 2015 | $1.28 |
| Net Income | Q1 2016 · Mar 25, 2016 | $227M |
| Net Income | Q1 2016 · Mar 27, 2015 | $105M |
| Operating Income | Q1 2016 · Mar 25, 2016 | $252M |
| Operating Income restated | Q1 2016 · Mar 27, 2015 | $187M |
| Cost Of Revenue | Q1 2016 · Mar 25, 2016 | $2.1B |
| Cost Of Revenue restated | Q1 2016 · Mar 27, 2015 | $2.28B |